electroCore (NASDAQ:ECOR) Upgraded at Brookline Cap M

Brookline Cap M upgraded shares of electroCore (NASDAQ:ECOR) to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports. Brookline Cap M also issued estimates for electroCore’s Q4 2025 earnings at ($0.39) EPS, FY2025 earnings at ($1.70) EPS, Q1 2026 earnings at ($0.33) EPS, Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.08) EPS, Q4 2026 earnings at ($0.01) EPS and FY2026 earnings at ($0.53) EPS.

A number of other equities research analysts have also recently commented on the company. HC Wainwright decreased their price target on electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a research note on Monday, January 26th. Brookline Capital Acquisition raised shares of electroCore to a “strong-buy” rating in a research report on Tuesday. Zacks Research cut shares of electroCore from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Finally, Wall Street Zen raised shares of electroCore from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Sell rating to the company’s stock. According to MarketBeat, electroCore currently has a consensus rating of “Moderate Buy” and an average price target of $22.00.

electroCore Stock Up 7.5%

Shares of NASDAQ ECOR traded up $0.38 during trading hours on Tuesday, hitting $5.45. 25,990 shares of the stock were exchanged, compared to its average volume of 85,068. electroCore has a 12 month low of $4.16 and a 12 month high of $19.49. The firm has a fifty day moving average price of $5.58 and a 200-day moving average price of $5.44. The company has a market cap of $43.60 million, a PE ratio of -3.19 and a beta of 0.48.

electroCore (NASDAQ:ECOR) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.07). The firm had revenue of $8.69 million during the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. As a group, equities analysts anticipate that electroCore will post -1.49 earnings per share for the current fiscal year.

Institutional Investors Weigh In On electroCore

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC lifted its holdings in shares of electroCore by 65.7% in the 2nd quarter. International Assets Investment Management LLC now owns 77,020 shares of the company’s stock valued at $407,000 after buying an additional 30,550 shares during the period. Cubist Systematic Strategies LLC purchased a new position in electroCore during the first quarter valued at approximately $153,000. NewEdge Advisors LLC lifted its holdings in electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after acquiring an additional 145,047 shares during the period. Jaffetilchin Investment Partners LLC lifted its holdings in electroCore by 26.7% in the second quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock valued at $221,000 after acquiring an additional 8,800 shares during the period. Finally, Tejara Capital Ltd acquired a new stake in shares of electroCore during the 4th quarter worth approximately $450,000. 26.74% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about electroCore

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: Brookline Capital Management upgraded ECOR to a “Strong-Buy” and published new estimates that point toward improving profitability — forecasting FY2026 EPS of ($0.53) and a near-breakeven Q4 2026 EPS of ($0.01), which investors may view as a catalyst for the stock. Zacks Upgrade
• Neutral Sentiment: Brookline released a detailed quarter-by-quarter EPS schedule (Q4 2025: ($0.39); Q1 2026: ($0.33); Q2 2026: ($0.12); Q3 2026: ($0.08); Q4 2026: ($0.01)) giving investors a roadmap for when improvement is expected, but these are analyst projections rather than company guidance. MarketBeat Estimates
• Negative Sentiment: Despite the upgrade, Brookline still models a sizable loss for FY2025 (forecast: ($1.70) EPS), which is worse than the current consensus full-year estimate of ($1.49) — a reminder that near-term profitability and cash flow remain risk factors. MarketBeat Estimates

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.